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tionnaire preoperatively and 6 weeks; 3, 6, 9, 12, and 18 months postoperatively; and yearly thereafter.
The EPIC-UD is composed of several questions, 4 of which address UI qualitatively (EPIC-UI). Further-
more, patients were asked to complete a global quality of life (QoL) questionnaire regarding continence.
The EPIC COV was calculated using receiver operating characteristic (ROC) analysis. Correlations be-
tween the EPIC-UI and quantitative QoL were evaluated using the Kendall-Tau test. RESULTS: We
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follow-up of 48 months (IQR, 30-78 months) and a median preoperative EPIC-UI score of 100 (IQR,
91.75-100). The ROC analysis for the distinction between EPIC-UI and the use of ￿1 pad/day yielded an
EPIC-UI COV of >85, which we termed the UI-85, with an area under the curve of 0.857 (P<0.0001).
A stronger correlation was seen between QoL scores and the UI-85 (1 year postoperatively: correla-
tion coefficient [CC], 0.592; P<0.0001) than between QoL and not using a pad (CC, 0.512; P<0.0001).
CONCLUSIONS: The calculated COV of the EPIC-UI for continence was 85. UI is a multidimensional
condition that cannot be adequately characterized by a single piece of information, such as pad usage
only. Hence, the UI-85 represents a nuanced and straightforward tool for monitoring and comparing
continence between different time points and cohorts in a multidimensional and objective manner.
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Purpose: To determine an objective cutoff value (COV) for urinary incontinence (UI) using the Expanded Prostate Cancer 
Composite (EPIC) score after radical prostatectomy (RP).
Methods: From 2004–2013, all RP patients at our institution completed the EPIC urinary domain (EPIC-UD) questionnaire 
preoperatively and 6 weeks; 3, 6, 9, 12, and 18 months postoperatively; and yearly thereafter. The EPIC-UD is composed of 
several questions, 4 of which address UI qualitatively (EPIC-UI). Furthermore, patients were asked to complete a global quali-
ty of life (QoL) questionnaire regarding continence. The EPIC COV was calculated using receiver operating characteristic 
(ROC) analysis. Correlations between the EPIC-UI and quantitative QoL were evaluated using the Kendall-Tau test. 
Results: We analyzed 239 patients with a median age of 63 years (interquartile range [IQR], 59–66 years), a median follow-up 
of 48 months (IQR, 30–78 months) and a median preoperative EPIC-UI score of 100 (IQR, 91.75–100). The ROC analysis for 
the distinction between EPIC-UI and the use of ≤1 pad/day yielded an EPIC-UI COV of >85, which we termed the UI-85, 
with an area under the curve of 0.857 (P<0.0001). A stronger correlation was seen between QoL scores and the UI-85 (1 year 
postoperatively: correlation coefficient [CC], 0.592; P<0.0001) than between QoL and not using a pad (CC, 0.512; P<0.0001). 
Conclusions: The calculated COV of the EPIC-UI for continence was 85. UI is a multidimensional condition that cannot be 
adequately characterized by a single piece of information, such as pad usage only. Hence, the UI-85 represents a nuanced and 
straightforward tool for monitoring and comparing continence between different time points and cohorts in a multidimen-
sional and objective manner.
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INTRODUCTION
Persistent urinary incontinence (UI) after radical prostatectomy 
(RP) is a significant side effect of a widely performed operation. 
While UI has a strong and sustained influence on a patient’s 
overall quality of life (QoL), it can have a complex, multidimen-
sional clinical appearance. For example, many continent patients 
still rely on absorbent security pads, while others do not mind 
or even notice wet pads. At the other end of the spectrum, oth-
ers can be devastated by minimal urinary leakage. Many in this 
latter group change pads multiple times per day though they are 
nearly dry. Furthermore, there are various types and sizes of 
pads. With such inconsistencies in mind, it is difficult to report, 
let alone assesses or compares, UI using existing methods. 
 In an attempt to make such a comparison, questionnaires 
have been developed to multidimensionally assess UI and to 
more accurately report and measure the true value of urinary 
continence [1]. More exhaustive questionnaires, such as the 
University of California, Los Angeles Prostate Cancer Index 
(UCLA-PCI) or the Functional Assessment of Cancer Therapy 
– Prostate, are promising, but they are subjective and lack exact 
quantitative cutoff values (COVs) [2]. 
 One widely used questionnaire is known as the Expanded 
Prostate Cancer Composite (EPIC) [3], an expansion of the 
original UCLA-PCI [2] that was developed to assess the pres-
ence of bothersome symptomatology after prostate cancer 
treatment. A section of this scoring system is solely dedicated to 
the assessment of urinary problems and is composed of 12 
questions that address continence, as well as hematuria, dys-
uria, and other voiding problems. In addition to requiring ob-
jective answers (such as the number of pads used daily), the 
EPIC also allows for subjective answers, such as “occasional” 
and “frequent.” In developing an objective method to better as-
sess UI post-RP, it is also important to recognize that many ex-
isting assessments such as the EPIC also lack a clear, uniform 
definition that differentiates continence from incontinence. 
This, in turn, can also restrict the objectivity of these assess-
ments. 
 Again, having uniform definitions and criteria would greatly 
facilitate the comparison of various patient populations and ex-
perimental trials. As quantitative assessments typically facilitate 
objectivity, we sought to establish a standardized definition of 
continence based on a quantitative COV. Between 2004 and 
2013, our institution prospectively collected functional and on-
cological data (including the EPIC score) from patients under-
going RP. Therefore, the aim of our investigation was to define a 
COV for the EPIC score by assessing the functional data of our 
long-term RP cohort.  
MATERIALS AND METHODS
Patient Population and Scoring System
The EPIC score is a self-assessment questionnaire that is widely 
used to evaluate a multitude of urological problems. Between 
2004 and 2013, all patients undergoing open retropubic RP at 
our institution were asked to complete the EPIC urinary do-
main (EPIC-UD), a subset of questions within the EPIC that 
focuses exclusively on urinary symptomatology in the context 
of prostate cancer treatment. Questions were answered in a 
semiquantitative manner, with scores ranging from 0 to 100 
points and higher scores signifying a better quality of urination 
[3]. Patients were also asked to globally quantify their QoL with 
regards to continence using a 7-point Likert scale (0, excellent; 
6, very bad). These questionnaires were completed preopera-
tively as well as at the following postoperative time points: 6 
weeks; 3, 6, 9, 12, and 18 months; and yearly thereafter. 
 All patients who underwent RP, with or without a nerve-
sparing approach, were included in our analysis.
Statistical Analysis
Our analysis focused on the EPIC-UI, which consists of the fol-
lowing 4 questions extracted from the EPIC-UD that are spe-
cific for UI [3]. Of note, when the EPIC was first used, a factor 
analysis consistent with this grouping was performed: 
-  Question 1: Over the past 4 weeks, how often have you leaked 
urine?
-  Question 4: Which of the following best describes your uri-
nary control over the last 4 weeks?
-  Question 5: How many pads or adult diapers per day did you 
usually use to control leakage during the last 4 weeks?
-  Question 6a: How big of a problem has (dripping or leaking 
urine) been for you during the last 4 weeks?
 To measure significant changes in continence over time, the 
Wilcoxon signed-rank test and the McNemar test for depen-
dent values were used. Receiver operating characteristic (ROC) 
curves were used to generate a COV from the EPIC-UI results, 
with the goal of identifying maximal specificity and sensitivity 
for not using a pad. 
 The Kendall-Tau test (with a 2-sided P-value) was applied to 
the cohort functional data to verify the applicability of the cal-
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culated total EPIC-UI COV. Here, we compared the correlation 
between QoL and both definitions of continence at all-time 
points. Bootstrapping was used to calculate the 95% confidence 
interval (CI).
 By applying the Kaplan-Meier method for regaining conti-
nence, the cumulative proportion of continent men and the 
median time to continence (including the 95% CI) were calcu-
lated for both definitions of continence.  
 Microsoft Access 2010 (Microsoft Corp., Redmond, WA, 
USA) was used for data acquisition, while IBM SPSS Statistics 
ver. 23.0 (IBM Co., Armonk, NY, USA) was utilized for calcula-
tions.  
RESULTS
A total of 239 patients with a median age of 63 years old (inter-
quartile range [IQR], 59–66 years) participated in the study 
(Table 1). The median follow-up time was 48 months (IQR, 30–
78 months). The median preoperative EPIC-UI score was 100 
points (IQR, 91.75–100 points). One year postoperatively, the 
EPIC-UI score decreased to 85.5 points (IQR, 58.5–100 points).
Calculation of the COV
An overview of continence development in our cohort (from 
the preoperative period to 10 years postoperatively) can be ob-
tained by looking at the mean EPIC-UI (Fig. 1). A significant 
increase in the mean EPIC-UI was observed postoperatively 
between 6 weeks and 12 months. After 12 months, this mean 
score remained stable and did not significantly increase or de-
crease. This, in conjunction with the fact that a sizable number 
of subjects remained in the study at 1 year (n=177), led us to 
use the 1-year time-point as the cutoff time-point for our COV 
calculations.
 As stated previously, the EPIC-UI is composed of 4 questions 
regarding urine leakage (item 1), control (item 4), number of 
pads per day (item 5), and urine loss (item 6a). With no use of a 
pad utilized as a hard criterion for satisfactory continence, 
scores for the 3 remaining questions (items 1, 4, and 6a) were 
summed and used to develop the COV. A significant correlation 
was seen between overall pad usage and the sum of the 3 re-
maining EPIC-UI questions, with a correlation coefficient of 
0.528 (95% CI, 0.439–0.609; P <0.0001). A ROC distribution 
comparing pad usage (0 vs. 1+ per day) against the sum of the 3 
remaining EPIC-UI questions yielded a COV for maximum 
sensitivity (0.767) and specificity (0.811) of 240, with an area 
under the curve of 0.857 (95% CI, 0.8–0.914; P<0.0001) (Fig. 2).
 To complete our calculations with EPIC-UI, the value for not 
using a pad (=100) was added to our previous COV of 240, 
Table 1. Baseline data of cohort (n=239)
Variable Value
Age (yr) 63 (59–66)
Follow-up (mo) 48 (30–78)
Deceased 8 (3.3)
Active surveillance 10 (4.2)
TURP 12 (5.0)
NS status
   Bilateral
   Unilateral
   NNS
   Not specified
176 (73.6)
143 (59.8)
33 (13.8)
54 (22.6)
9 (3.8)
Senior surgeon 154 (64.4)
Preoperative PSA (ng/mL) 5.77 (4.3–7.72)
Preoperative PSA density 0.17 (0.12–0.25)
Prostate volume (mL) 33.35 (25.23–44.55)
Maximum biopsy-Gleason
   6
   7
   8–9
110 (46.0)
98 (41.0)
30 (12.6)
Clinical tumor status
   cT1
   cT2
   cT2a
   cT2b
   cT2c
   cT3
173 (72.4)
65 (27.2)
31 (13.0)
19 (7.9)
15 (6.3)
1 (0.4)
Final Gleason
   6
   7
   8–10
67 (28.0)
132 (55.2)
40 (16.7)
Pathological tumor status
   pT2
   pT3
   pT4
178 (74.5)
58 (24.3)
1 (0.4)
Margin
   R0
   R1
   R2
166 (69.5)
59 (24.7)
14 (5.9)
Lymph node status
   pN0/X
   pN1
   Metastasis
171/176 (97.2)
5/176 (2.8)
3 (1.26)
Values are presented as median (range) or number (%).
TURP, transurethral resection of the prostate; NS, nerve-sparing; NNS, 
non–nerve-sparing; PSA, prostate-specific antigen. 
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yielding a new value of 340. Thus, the COV was defined as an 
average score of 85 (=340/4) (UI-85). Scores greater than 85 
predicted no usage of pads.
Verification of the UI-85
Based on the assumption that QoL is the major concern of pa-
tients suffering from UI, we then decided to compare quantita-
tive QoL scores against the UI-85 as well as against the old 
standard of no pad use. This comparison was designed to assess 
the accuracy of competing definitions of continence (UI-85 vs. 
pad/no-pad). Starting at 9 months postoperatively, the data re-
vealed a stronger correlation between QoL and the UI-85 than 
between QoL and the binary definition of continence (Fig. 3). 
Application of the UI-85
The percentage of continent men defined according to the UI-
85 at each time point was also calculated and graphically pre-
sented (Fig. 4). A significant increase in the number of conti-
Fig. 1. Mean EPIC-UI scores (95% confidence interval) over a time period of 10 years. The table shows the mean EPIC-UI scores with 
standard deviations (SDs) and significant P-values according to the Wilcoxon signed-rank test for dependent values. Arrow indicates 
a significant increase. EPIC-UI, Expanded Prostate Cancer Composite urinary incontinence; RP, radical prostatectomy.
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Time Mean±SD Median Wilcoxon signed rank test
Preoperative 92.7±10.9 100
↓P<0.001
↓P<0.0001
↓P=0.011
↓P=0.016.
6 Weeks 40.5±32.7 32.25
3 Months 59.9±30.1 62.5
6 Months 73.1±25.0 79.25
9 Months 74.4±23.0 79.25
1 Years 76.1±24.6 85.5
1.5 Years 77.3±24.8 85.5
2 Years 78.1±23.6 85.5
3 Years 79.3±22.6 85.5
4.5 Years 78.0±22.2 83.5
6.5 Years 73.8±27.2 83.5
10 Years 80.2±23.2 91.75
Fig. 2. ROC curve for pad usage with remaining EPIC-UI ques-
tions, including visualization of the COV at maximum sensitiv-
ity and specificity. ROC, receiver operating characteristic; EPIC-
UI, Expanded Prostate Cancer Composite urinary inconti-
nence; COV, cutoff value; AUC, area under the curve.
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Fig. 3. Graphical overview of the correlation coefficient (CC) 
and 95% confidence intervals measured by Kendal-Tau test and 
bootstrapping over time (blue: the no-pad definition of urinary 
incontinence; red: the UI-85 definition of urinary inconti-
nence). QoL, quality of life; UI, urinary incontinence; RP, radi-
cal prostatectomy.
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nent patients took place between 6 weeks and 6 months post-
operatively (UI-85; P <0.0001), after which no significant 
changes occurred. For patients with an EPIC-UI score of 100 
(signifying no issues with urinary continence), the data demon-
strate a significant (P<0.0001) increase in continence up to 3 
years postoperatively, followed by a plateau thereafter. In the 
same manner, QoL answers regarding continence can be shown 
over time (Fig. 4). For instance, the percentages of patients with 
EPIC-UI scores >85 and =100 compared against QoL conti-
nence answers (such as “satisfied” or “excellent”) are similar 
(Fig. 4).
 One year postoperatively, the Kaplan-Meier curve (Fig. 5) 
demonstrated a cumulative continence rate of 52.5% (95% CI, 
46%–59%) using the UI-85 and 59.7% (95% CI, 53.4%–66%) 
using the binary continence definition. By the same analyses, 
the median time to regaining continence was 12 months (IQR, 
7.4–16.6 months) using the UI-85 and 9 months (IQR, 6.4–11.6 
months) when UI was defined as not using a pad. 
DISCUSSION
Several methods have been developed for determining and 
documenting UI, and they range from simple to highly com-
plex. However, no existing method accurately characterizes the 
multidimensional nature of UI. We surmised that an ideal 
method would be (1) objective, (2) easy to understand for the 
patient, (3) easy to collect as a healthcare provider, and (4) easy 
to interpret accurately. We consider these criteria to be equally 
important and, to our knowledge, such an ideal test does not 
yet exist. Therefore, our aim with this paper was to demonstrate 
our attempt at developing a quantitative COV based on an ex-
isting exam: the EPIC-UD. 
 Thus far, the gold standard for assessing UI has been simply 
to ask a patient regarding his or her use of absorbent pads for 
urine leakage. The use of such a pad after RP would imply some 
degree of persistent UI. While this method fulfills 3 of the 4 cri-
teria listed above, it disregards the fact that this assessment 
could be strictly or liberally interpreted. For instance, many 
physicians consider a patient to be continent even if that patient 
occasionally relies on a security pad [4]. Additionally, the need 
for a pad is not well-defined, which negatively affects the accu-
racy of answers to this question. For example, an incontinent 
patient who loses urine weekly and refuses to wear pads could 
hardly be accurately assessed using this criterion. Conversely, a 
careful man who hardly ever loses urine, but changes pads mul-
tiple times daily to maintain his hygiene, may be misinterpreted 
to be reliant on pads when he is actually not. Therefore, there is 
a need for standardized criteria that accurately classify inconti-
nence as well as its management. 
 To instill a degree of objectivity, some authors have weighed 
patients’ pads before and after having patients perform several 
Fig. 5. Kaplan-Meier curves for returning to continence using 
both definitions (UI-85 and no-pad) to show the development 
over time for the whole cohort. UI, urinary incontinence; RP, 
radical prostatectomy.
Time after RP (yr)
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0 2 4 6 8 10Fig. 4. QoL (continence) and proportion of continent patients 
over time. Blue (EPIC): percentage of continent men by UI-85 
(light blue) and patients without problems concerning inconti-
nence (dark blue; EPIC-UI =100) over a period of 10 years. 
Green (QoL): percentage of patients who were satisfied (light 
green) and very satisfied (dark green). EPIC-UI, Expanded 
Prostate Cancer Composite urinary incontinence; QoL, quality 
of life.
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standardized exercises [5,6]. However, such an approach is like-
ly to be too cumbersome for daily clinical practice. This is fur-
ther exacerbated by the lack of a routine assessment at all fol-
low-up visit. Despite such drawbacks, such questionnaires have 
the potential to provide accurate clinical data even if they are 
not the easiest or most practical to implement. In this study, we 
present an EPIC score-based COV for urinary continence. 
These 4 questions solely addressing urinary continence were 
utilized to generate to a sub-score known as the EPIC-UI. 
 In this paper, we sought to determine an objective COV 
based on the EPIC scoring system. Our calculations identified a 
COV of 85 (UI-85) for continence. To assess the clinical rele-
vance of this COV, we compared it against the binary definition 
of continence (i.e., pad or no-pad) as well as to QoL. In these 
calculations, the UI-85 was strongly correlated with QoL; this 
correlation was stronger than that between QoL and the binary 
definition of continence. 
 Furthermore, we applied the UI-85 to our cohort of RP pa-
tients. While the cumulative continence rates were similar for 
both the UI-85 and the binary definition (52.5% and 59.7%, re-
spectively), the median time to regaining continence was longer 
using the UI-85 (12 months vs. 9 months) for the same cohort. 
Hence, it appears that the UI-85 is a more sensitive and nuanced 
tool for describing postoperative continence rehabilitation, as it 
could detect slight increases in continence between months 9 
and 12, whereas the binary definition plateaued earlier. 
 We also analyzed and compared the functional outcomes of 
our cohort. The percentage of men with EPIC-UI scores >85 at 
different time points demonstrated a high degree of similarity 
to the percentage of men who reported that they were “satis-
fied” with their QoL. This further corroborates the clinical rele-
vance of the UI-85. We recognize that there are many different 
ways of measuring continence. For instance, weighing pads af-
ter predefined exercises is a relatively simple way of doing so. 
However, it is resource-intensive for both patients and their 
physicians. In contrast, the EPIC-UI can easily be extracted 
from the widely used EPIC score, making it an uncomplicated 
tool for monitoring continence over time or comparing the uri-
nary continence between different cohorts. 
 Advances in operative techniques have done little to alleviate 
the doubt surrounding the impact of these approaches and 
technologies on UI [7]. Some trials have demonstrated better 
recovery of early incontinence (3–6 months postoperatively) 
following robotic RP, whereas other trials have suggested the 
opposite [8-10]. While the achievement and quality of early 
continence are important to understand, the majority of RP pa-
tients typically have a long life expectancy, making the analysis 
of long-term continence (more than 6 months postoperatively) 
outcomes dramatically more important and more clinically rel-
evant.
 While the results in our cohort only differed by 1.9% at the 
10-year time-point, our Kaplan-Meier curves revealed a faster 
rate of increase of continence using the no-pad definition than 
when the UI-85 was used. At 2 years postoperatively, the pla-
teau for the no-pad definition was reached, whereas continence 
levels per UI-85 plateaued after 3 years postoperatively. Thus, 
the EPIC-UI COV of 85 (i.e., the UI-85) appears to represent a 
more accurate and nuanced tool for monitoring postoperative 
continence.
 When applying the UI-85, it is important to recognize that 
some men will eventually demonstrate slight UI. Hence, the 
UI-85 is not completely equivalent to no-pad. Nonetheless, our 
calculations showed that patients with an EPIC-UI >85 were 
more likely to be satisfied with their degree of urinary conti-
nence. Over a several-year timeframe, it is possible that patients 
may accept a slight degree of incontinence, potentially leading 
to a bias (for e.g., reporting better outcomes despite unchanged 
continence or incontinence). We attempted to account for this 
problem by basing our calculations on data no older than the 
1-year postoperative period, as practically, RP patients are less 
likely to enter the mental state of resignation at 1 year than at a 
later follow-up time. 
 Another consideration in the broader milieu of urinary con-
tinence is that the impact of nerve-sparing prostatectomy on 
urinary continence is still unclear and remains a matter of on-
going discussion [11-17]. In our cohort, only 39 patients who 
completed the EPIC questionnaire at 1 year postoperatively did 
not undergo nerve-sparing surgery. Furthermore, these patients 
were statistically significantly older and had a higher tumor 
burden, both of which could have contributed to a substantial 
amount of bias if the ROC calculations for COVs had been per-
formed for nerve-sparing and non–nerve-sparing groups sepa-
rately. Hence, to generate a universally applicable definition, pa-
tients with and without nerve-sparing RP were collectively in-
cluded in the study. 
  In conclusion, the COV of the EPIC-UI for continence was 
found to be 85 (the UI-85). The UI-85 represents a nuanced 
and straightforward tool to monitor and compare urinary con-
tinence between different time points and cohorts in a multidi-
mensional and objective manner. 
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